Skip to main content
Premium Trial:

Request an Annual Quote

IP Watch: Illumina, Abbott, Roche, Rheonix, Firefly, Others Win US Patents


Lawrence Livermore National Security and The University of California have been awarded US Patent No. 8,610,032, "Laser heating of aqueous samples on a micro-optical-electro-mechanical system."

Neil Beer and Ian Kennedy are named as inventors.

Ibis Biosciences (Abbott Laboratories) has been awarded US Patent No. 8,609,430, "Sample processing units, systems, and related methods."

Steven Hofstadler, Jared Drader, Jose Gutierrez, Paul Gleason, Rex Bare, Robert Miller, and Jeffrey Smith are named as inventors.

Illumina has been awarded US Patent No. 8,609,341, "Uniform fragmentation of DNA using binding proteins."

Frank Steemers and Jonathan Boutell are named as inventors.

Roche has been awarded US Patent No. 8,609,340, "Control nucleic acids for multiple parameters."

Meike Eickhoff, Ellen Fiss, Joachim Glaubitz, Niclas Hitziger, Stephen Will, and Dirk Zimmermann are named as inventors.

454 Life Sciences (Roche) has been awarded US Patent No. 8,609,339, "System and method for emulsion breaking and recovery of biological elements."

Yue Suo is named as the inventor.

Firefly BioWorks has been awarded US Patent No. 8,609,337, "Nucleic acid detection and quantification by post-hybridization labeling and universal encoding."

Daniel Pregibon, Isaac Stoner, Andreas Windemuth, and Timothy Erps are named as inventors.

Rheonix has been awarded US Patent No. 8,609,039, "Microfluidic systems and control methods."

Peng Zhou and Lincoln Young are named as inventors.

The University of British Columbia has been awarded US Patent No. 8,608,929, "Apparatus and methods for concentrating and separating particles such as molecules."

Andrea Marziali and David Broemeling are named as inventors.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.